Evidence map›Paper›PMID 35047906›Full record

ArticleFrontiers in medical technology2021

Bridging the Antimicrobial Activity of Two Lactoferricin Derivatives in

Lisa Marx, Enrico F Semeraro, Johannes Mandl, Johannes Kremser, Moritz P Frewein, Nermina Malanovic, Karl Lohner, Georg Pabst

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medical technology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Bactericidal Activity toAntibiotics (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Lisa MarxDepartment of Biophysics, Institute of Molecular Biosciences, University of Graz, Graz, Austria.
Enrico F SemeraroDepartment of Biophysics, Institute of Molecular Biosciences, University of Graz, Graz, Austria.
Johannes MandlDepartment of Biophysics, Institute of Molecular Biosciences, University of Graz, Graz, Austria.
Johannes KremserDepartment of Biophysics, Institute of Molecular Biosciences, University of Graz, Graz, Austria.
Moritz P FreweinDepartment of Biophysics, Institute of Molecular Biosciences, University of Graz, Graz, Austria.
Nermina MalanovicDepartment of Biophysics, Institute of Molecular Biosciences, University of Graz, Graz, Austria.
Karl LohnerDepartment of Biophysics, Institute of Molecular Biosciences, University of Graz, Graz, Austria.
Georg PabstDepartment of Biophysics, Institute of Molecular Biosciences, University of Graz, Graz, Austria.
BioTechMed-Graz · ATUniversity of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We coupled the antimicrobial activity of two well-studied lactoferricin derivatives, LF11-215 and LF11-324, in

Indexed as

antimicrobial peptidesdye-leakage assaylactoferricinminimum inhibitory concentrationpartitioningsmall-angle X-ray scatteringtryptophan fluorescencezeta-potential

Identifiers

PMID35047906
PMCPMC8757871
OpenAlexW3133447151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.